Protagonist Therapeutics Inc’s recently made public that its Director Waddill William D. unloaded Company’s shares for reported $0.24 million on Aug 27 ’25. In the deal valued at $59.25 per share,4,000 shares were sold. As a result of this transaction, Waddill William D. now holds 9,130 shares worth roughly $0.53 million.
Then, WILLIAM WADDILL bought 4,000 shares, generating $227,960 in total proceeds.
Before that, PATEL DINESH V PH D sold 10,415 shares. Protagonist Therapeutics Inc shares valued at $570,534 were divested by the President and CEO at a price of $54.78 per share. As a result of the transaction, PATEL DINESH V PH D now holds 520,603 shares, worth roughly $30.38 million.
Citigroup initiated its Protagonist Therapeutics Inc [PTGX] rating to a Buy in a research note published on June 17, 2025; the price target was $72. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in early December with a ‘”a Neutral”‘ rating. BMO Capital Markets began covering PTGX with “an Outperform” recommendation on December 06, 2024. Wedbush started covering the stock on November 05, 2024. It rated PTGX as “an Outperform”.
Price Performance Review of PTGX
On Tuesday, Protagonist Therapeutics Inc [NASDAQ:PTGX] saw its stock jump 3.86% to $58.36. Over the last five days, the stock has lost -0.83%. Protagonist Therapeutics Inc shares have risen nearly 38.89% since the year began. Nevertheless, the stocks have risen 51.19% over the past one year. While a 52-week high of $61.89 was reached on 08/28/25, a 52-week low of $33.31 was recorded on 02/25/25.
Levels Of Support And Resistance For PTGX Stock
The 24-hour chart illustrates a support level at 55.47, which if violated will result in even more drops to 52.58. On the upside, there is a resistance level at 60.28. A further resistance level may holdings at 62.20.
How much short interest is there in Protagonist Therapeutics Inc?
A steep rise in short interest was recorded in Protagonist Therapeutics Inc stocks on 2025-08-15, growing by 0.13 million shares to a total of 6.31 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 6.18 million shares. There was a rise of 2.01%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 24, 2024 when TD Cowen began covering the stock and recommended ‘”a Buy”‘ rating along with a $65 price target.
